Literature DB >> 28509305

AP-VAS 2012 case report: two patients with rheumatoid arthritis suspected of relapsed microscopic polyangiitis after initiation of dialysis.

Mai Sugahara1, Takahiro Nishi1, Shinji Tanaka1, Noriaki Kurita1, Keiko Sai1, Tatsuya Kano2, Kyosuke Nishio2, Tokuichiro Sugimoto1, Naobumi Mise3.   

Abstract

We report two patients with rheumatoid arthritis (RA) who were suspected of microscopic polyangiitis during maintenance dialysis. Case 1 was a 52-year-old woman with RA diagnosed at the age of 38 years and treated successfully with gold compounds. At the age of 43 years, she presented with progressive renal dysfunction and abnormal urine sediments, and a renal biopsy revealed crescentic nephritis with advanced glomerular sclerosis. Myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) was not measured on that occasion. She reached end-stage renal failure within 4 months and started peritoneal dialysis. Eight years later, soon after she was switched to hemodialysis, she developed fever of unknown origin. MPO-ANCA was elevated to 37 EU, although there were no other signs or symptoms suggestive of vasculitis. After taking prednisolone orally (10 mg/day), her fever withdrew, and MPO-ANCA became undetectable. Case 2 was a 71-year-old woman with RA diagnosed at the age of 60 years and treated with gold compounds. She developed renal failure of unknown cause (no biopsy was performed), and started hemodialysis at the age of 69 years. One year later, she presented with fever and subsequently developed cough with hemoptysis. MPO-ANCA was elevated to 62 EU. Treatment with azathioprine 50 mg and prednisolone 35 mg daily brought remarkable clinical improvement, and MPO-ANCA became undetectable. These cases highlight the importance of measuring ANCA even in RA patients on dialysis who present with fever of unknown origin or with underlying kidney disease of uncertain etiology.

Entities:  

Keywords:  Hemodialysis; Microscopic polyangiitis; Myeloperoxidase antineutrophil cytoplasmic antibody; Rheumatoid arthritis

Year:  2013        PMID: 28509305      PMCID: PMC5411558          DOI: 10.1007/s13730-013-0081-2

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  22 in total

1.  Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis.

Authors:  M U Qarni; D E Kohan
Journal:  Clin Nephrol       Date:  2000-07       Impact factor: 0.975

2.  Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial.

Authors:  J Himmelfarb; P Zaoui; R Hakim
Journal:  Kidney Int       Date:  1992-02       Impact factor: 10.612

3.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

4.  Clinical course and symptomatic prediagnostic period of patients with Wegener's granulomatosis and microscopic polyangiitis.

Authors:  T Schleiffer; B Burkhard; P Klooker; H Brass
Journal:  Ren Fail       Date:  1998-05       Impact factor: 2.606

5.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

Review 6.  Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with rheumatoid arthritis: a comparison of patients without rheumatoid arthritis.

Authors:  Noriaki Kurita; Naobumi Mise; Akiko Fujii; Masaya Mori; Keiko Sai; Takahiro Nishi; Takeshi Suzuki; Hitoshi Tagawa; Tokuichiro Sugimoto
Journal:  Clin Exp Nephrol       Date:  2010-03-26       Impact factor: 2.801

7.  MPO-ANCA necrotizing glomerulonephritis related to rheumatoid arthritis.

Authors:  T Messiaen; P M'bappé; J J Boffa; R Khayat; B Mougenot; J Rossert; P Ronco
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

8.  Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.

Authors:  N Yorioka; Y Taniguchi; D Amimoto; H Miyata; M Yamakido; T Taguchi
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

9.  Activated and regulatory T lymphocyte populations in chronic hemodialysis patients.

Authors:  H Rabb; S J Agosti; S Pollard; P A Bittle; G Ramirez
Journal:  Am J Kidney Dis       Date:  1994-09       Impact factor: 8.860

10.  [A case of MPO-ANCA-related vasculitis with chronic alveolar hemorrhage].

Authors:  Hideto Goto; Takasi Ogura; Hirosi Takahasi; Yasuhiro Yosiike; Yuuji Watanuki; Tae Iwasawa; Takuya Yazawa
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2004-03
View more
  1 in total

1.  Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis.

Authors:  Haiting Wu; Yiyun Lu; Rongrong Hu; Wei Ye; Yubing Wen; Jianfang Cai; Hang Li; Xuemei Li
Journal:  BMC Nephrol       Date:  2022-04-22       Impact factor: 2.585

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.